“Ne-ne crack” is a street term for a substance known for its intense and hazardous outcomes. The drug’s effects are notoriously erratic, leading to a range of serious physical and psychological consequences for the user.
Composition and Method of Use
Ne-ne crack combines crack cocaine and phencyclidine (PCP). Crack cocaine is a potent central nervous system stimulant, while PCP is a dissociative anesthetic that produces hallucinations and a sense of detachment from reality. This combination creates a drug with a complex and volatile chemical profile.
The primary method of use is smoking. Users lace a piece of crack cocaine with liquid or powdered PCP, heat the mixture, and inhale the resulting vapor. This method allows the chemicals to be absorbed rapidly through the lungs, leading to a swift onset of effects.
The appeal lies in the synergistic interaction between the two drugs. The stimulant properties of crack cocaine merge with the hallucinogenic and dissociative effects of PCP. This creates an intense experience distinct from using either drug alone, but it also amplifies the dangers of both components.
Immediate Effects on the User
Users experience a rush of contradictory sensations. The crack cocaine provides euphoria, heightened alertness, and a surge of energy. Simultaneously, PCP induces perceptual distortions, including hallucinations, “out of body” experiences, and a disconnect from one’s surroundings. This clash between a stimulant and a dissociative anesthetic creates a chaotic and disorienting state.
The psychological impact is marked by unpredictability. A person can swing from feelings of grandiosity and invincibility to intense paranoia, agitation, and aggression. These shifts in mood and perception occur without warning, making the user’s behavior erratic. Delusions can also create a false sense of being impervious to harm.
The body is placed under immense stress. The stimulant effects cause a rapid heart rate, increased blood pressure, and excessive sweating. Users also exhibit a loss of muscle control and coordination, impairing their ability to navigate their environment safely.
Severe Risks and Dangers
The combination of a stimulant and a dissociative drug places an enormous strain on the cardiovascular system. This can lead to a sudden cardiac event, respiratory arrest, or seizures. An overdose is a significant risk due to the unpredictable potency of street drugs and the synergistic effects of the two components.
The intense paranoia and hallucinations can lead to violent or bizarre behavior. Under the drug’s influence, individuals may act on delusions with no comprehension of real-world consequences. This altered state removes normal inhibitions and the ability to perceive danger accurately, making them a potential threat to themselves or others.
The inability to feel pain from PCP creates a serious hazard. Users may sustain severe injuries without realizing it, which can delay medical attention and allow treatable injuries to become life-threatening. This numbness, combined with aggression and paranoia, makes encounters with users unpredictable for first responders.
Long-Term Health Consequences
Chronic use leads to a high likelihood of severe psychological and physical dependence. The short-lived high of crack cocaine encourages compulsive use, while PCP contributes to a strong psychological addiction. This dual dependency makes quitting difficult and relapse common.
Prolonged use can cause lasting neurological damage. Users may experience persistent memory loss, speech difficulties, and a decline in cognitive function. These effects are linked to the neurotoxic properties of the substances, which damage brain cells and alter brain chemistry over time, impairing a person’s ability to function.
Chronic mental health disorders are a frequent outcome for long-term users. Common issues include severe depression, anxiety, and social withdrawal. Repeated use can also trigger a long-lasting psychosis with symptoms similar to schizophrenia, such as hallucinations and delusions that may persist even after cessation of the drug.